Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Parenteral Drugs (India) Ltd

PDPL.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$0.03

Market Cap $1.01M · Vol 1.06K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$1.01M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

50.00

Momentum

Beta

N/A

vs Market

52W High

N/A

0.00% below

52W Low

N/A

7.41% above

Volume

1.06K

Avg 0

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

N/A

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Parenteral Drugs (India) Ltd (PDPL.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PDPL.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

N/A

YTD

N/A

+1.34%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$1.12M
Net Income	$-10,060,671.00
Revenue Growth (YoY)	-31.01%
Gross Margin	-436.87%
Operating Margin	-649.25%
Net Profit Margin	-898.77%
ROE	N/A
ROA · ROIC	-20.74% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.26
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	29.82M

Technical Indicators

50-Day SMA	$0.03
200-Day SMA	$0.03
RSI (14)	50.00
Beta	N/A
52-Week High	N/A
52-Week Low	N/A

Volume Today	1.06K
Avg Daily Volume (30D)	0
Relative Volume	N/Ax
Volatility (10D)	0.00
Volatility (30D)	0.00
Free Float	N/A

Analyst Consensus

N/A

Current Price $0.03

Mean Target N/A

52W LowN/A 52W HighN/A

Current

Target

N/A N/A

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S6S6R0

ISININE904D01019

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Parenteral Drugs (India) Limited is engaged in the manufacturing of pharmaceutical products. It also manufactures intravenous (IV) infusion, inhalation, and veterinary infusion. It offers products in various categories, including IV fluids, oncology, anesthesia and exports. Its IV Fluids include Carbohydrated and Electrolytes, such as Dextrose IP 5%, 10%, 20%, Dextrose IP 25% , and Ringer Lactate IP; Diuretics, such as Mannitol 10%, 20% and Manidex (Mannitol 10% with Glycerine 10%); Dialysis and Irrigation Solution, such as Peritoneal Dialysis Solution with 1.7% Dextrose and 1.5% Glycine; Anti-infective and Anti-fungal, such as Ciprofloxacin 200mg and Metronidazole 500mg and others , such as Tamolgan (Paracetamol 1000mg) and PD-Invert (10% Invert Sugar). Its Oncology product mix includes 5 FU-PAR and BAZIPAR. Its Anesthesia product mix includes Sevoplan (Sevoflurane 100/250ml) and Isoplan (Isoflurane 100/250ml).